Connect with us
[bsa_pro_ad_space id=12]

Health

Transgender activists are threatening the author of scathing UK report on child ‘sex changes’

Published

7 minute read

Dr. Hilary Cass, author of the Cass Review, YouTube screenshot

From LifeSiteNews

By Jonathon Van Maren

That a female physician has been advised to stop taking the bus or the train because she might be assaulted by trans activists for attempting to protect children from a horrifying – and ongoing – medical scandal should be shocking to us all.

Dr. Hilary Cass, the 66-year-old physician who led the team behind the 366-page Cass Review, has become a target of trans activists as the repercussions of her findings reverberate through the political and medical establishment. The abuse is not confined merely to online; she has been advised not to use public transport for her own safety. 

In an interview with the Times, Cass stated that critics of her report are putting children “at risk” by spreading “straight disinformation” and that criticisms, thus far, have been “completely wrong.” One Labour MP accused Cass of ignoring “100 transgender studies” in her findings. This, says Cass, is disingenuous in the extreme. 

“I have been really frustrated by the criticisms, because it is straight disinformation,” Cass told the Times. “It started the day before the report came out when an influencer put up a picture of a list of papers that were apparently rejected for not being randomized control trials. That list has absolutely nothing to do with either our report or any of the papers.” 

“If you deliberately try to undermine a report that has looked at the evidence of children’s healthcare, then that’s unforgiveable,” she continued. “You are putting children at risk by doing that.” The 100 papers that were allegedly “left out” of the report, Cass noted, were each individually examined by her team of researchers, who “pulled the results from the ones that were high quality and medium quality, which was 60 out of 103.” 

Cass’s crime, of course, is that her report debunks the transgender narrative. She has been encouraged, she told the Times, by the impact of her report in many quarters – but the response elicited from trans activists has been “pretty aggressive” and she noted that the vitriol spiked each time the Cass Review reported something “people don’t like.”  

“There are some pretty vile emails coming in at the moment,” she said of the profanity-laced digital missives coming her way. “Most of which my team is protecting me from, so I’m not getting to see them. What dismays me is just how childish the debate can become. If I don’t agree with somebody then I’m called transphobic or a TERF [trans-exclusionary radical feminist].” 

When asked if the vitriol was wearing her down, Cass responded: 

No… it’s personal, but these people don’t know me. I’m much, much more upset and frustrated about all the disinformation than I am about the abuse. The thing that makes me seethe is the misinformation. I’m not going on public transport at the moment, following security advice, which is inconvenient.

Indeed, six clinics, she said, refused to share research into the impact of puberty blockers – Cass called their reaction “coordinated” and “ideologically driven” and noted that “they were not particularly friendly to us when we approached.” 

Although Cass will not be carrying out the recently-announced review of adult gender clinics, she did condemn GenderGP – which we have reported on in this space several times – for continuing to advertise and prescribe puberty blockers, noting that the “care” provided by Dr. Helen Webberley “certainly doesn’t come anywhere near anything one would recognise as adequate in terms of a proper assessment and exploration.”  

That a female physician has been advised to stop taking the bus or the train because she might be assaulted by trans activists for attempting to protect children from a horrifying – and ongoing – medical scandal should be shocking to us all. The last few years have desensitized us to this sort of behavior. Fortunately, it appears that the Cass Review’s findings are having a seismic impact on the debate trans activists desperately tried to avoid, nonetheless. 

Featured Image

Jonathon Van Maren is a public speaker, writer, and pro-life activist. His commentary has been translated into more than eight languages and published widely online as well as print newspapers such as the Jewish Independent, the National Post, the Hamilton Spectator and others. He has received an award for combating anti-Semitism in print from the Jewish organization B’nai Brith. His commentary has been featured on CTV Primetime, Global News, EWTN, and the CBC as well as dozens of radio stations and news outlets in Canada and the United States.

He speaks on a wide variety of cultural topics across North America at universities, high schools, churches, and other functions. Some of these topics include abortion, pornography, the Sexual Revolution, and euthanasia. Jonathon holds a Bachelor of Arts Degree in history from Simon Fraser University, and is the communications director for the Canadian Centre for Bio-Ethical Reform.

Jonathon’s first book, The Culture War, was released in 2016

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

Trump signs order reclassifying marijuana as Schedule III drug

Published on

From The Center Square

By

President Donald Trump signed an executive order moving marijuana from a Schedule I to a Schedule III controlled substance, despite many Republican lawmakers urging him not to.

“I want to emphasize that the order I am about to sign is not the legalization [of] marijuana in any way, shape, or form – and in no way sanctions its use as a recreational drug,” Trump said. “It’s never safe to use powerful controlled substances in recreational manners, especially in this case.”

“Young Americans are especially at risk, so unless a drug is recommended by a doctor for medical reasons, just don’t do it,” he added. “At the same time, the facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered.”

Under the Controlled Substances Act, Schedule I drugs are defined as having a high potential for abuse and no accepted medical use. Schedule III drugs – such as anabolic steroids, ketamine, and testosterone – are defined as having a moderate potential for abuse and accepted medical uses.

Although marijuana is still illegal at the federal level, 24 states and the District of Columbia have fully legalized marijuana within their borders, while 13 other states allow for medical marijuana.

Advocates for easing marijuana restrictions argue it will accelerate scientific research on the drug and allow the commercial marijuana industry to boom. Now that marijuana is no longer a Schedule I drug, businesses will claim an estimated $2.3 billion in tax breaks.

Chair of The Marijuana Policy Project Betty Aldworth said the reclassification “marks a symbolic victory and a recalibration of decades of federal misclassification.”

“Cannabis regulation is not a fringe experiment – it is a $38 billion economic engine operating under state-legal frameworks in nearly half of the country that has delivered overall positive social, educational, medical, and economic benefits, including correlation with reductions in youth use in states where it’s legal,” Aldworth said.

Opponents of the reclassification, including 22 Republican senators who sent Trump a warning letter Wednesday, point out the negative health impact of marijuana use and its effects on occupational and road safety.

“The only winners from rescheduling will be bad actors such as Communist China, while Americans will be left paying the bill. Marijuana continues to fit the definition of a Schedule I drug due to its high potential for abuse and its lack of an FDA-approved use,” the lawmakers wrote. “We cannot reindustrialize America if we encourage marijuana use.”

Marijuana usage is linked to mental disorders like depression, suicidal ideation, and psychotic episodes; impairs driving and athletic performance; and can cause permanent IQ loss when used at a young age, according to the Substance Abuse and Mental Health Administration.

Additionally, research shows that “people who use marijuana are more likely to have relationship problems, worse educational outcomes, lower career achievement, and reduced life satisfaction,” SAMHA says.

Continue Reading

Health

Saskatchewan woman approved for euthanasia urged to seek medical help in Canada rather than US

Published on

From LifeSiteNews

By Anthony Murdoch

Saskatchewan Premier Scott Moe encouraged Jolene Van Alstine, who has a rare disease, to work with his government on a solution.

Saskatchewan Premier Scott Moe is urging a woman with a rare disease, who has been approved to die by euthanasia because she can’t get proper care, to instead work with his government on a solution.

As reported by LifeSiteNews last week, Saskatchewan resident Jolene Van Alstine was approved to die by state-sanctioned euthanasia because she has had to endure long wait times for what she considers to be proper care for a rare parathyroid disease.

Van Alstine’s condition, normocalcemic primary hyperparathyroidism (nPHPT), causes her to experience vomiting, nausea, and bone pain.

As a result of Van Alstine’s frustrations with the healthcare system, she applied for Canada’s Medical Assistance in Dying (MAiD) and was approved for a January 7, 2026, death date.

Her case drew the attention of American media personality Glenn Beck, who has been in contact with Van Alstine to determine whether she can get the surgery done in the United States. Even the administration of U.S. President Donald Trump has been briefed on the matter.

According to Moe, Van Alstine has taken her case to Saskatchewan Health Minister Jeremy Cockrill, asking for help.

“There has been an opportunity to see specialists in Saskatchewan and outside of Saskatchewan, and those conversations about maybe potentially seeing additional specialists continue with the minister’s office and the Ministry of Health,” Moe said yesterday at a press conference.

“I would hope that she’d continue to work with the Ministry of Health, because I think there’s work going on to see even additional specialists at this point,”

A recent Euthanasia Prevention Coalition report revealed that Canada has euthanized 90,000 people since 2016, the year it was legalized.

As reported by LifeSiteNews, over 23,000 Canadians have died while on wait lists for medical care as Prime Minister Mark Carney’s Liberal government focuses on euthanasia expansions.

Continue Reading

Trending

X